Intuitive Surgical, Inc.
Foreign stocks · NASDAQ · Healthcare · Medical devices
Makes the da Vinci surgical robot that hospitals use for minimally invasive surgery. Most revenue comes from instruments and consumables that must be bought for every procedure, not just the machine itself
For every 100 dollars of sales: cost of sales 34 · operating expenses 37 · tax and other items 1 · leaving 28 as net profit
Investors in Thailand can buy ISRG through 10 mutual funds open to retail investors. Most of them (10 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds ISRG.
| Fund | ISRG weight | How it invests | 1-year return |
|---|---|---|---|
 ONE-MEDTECHONE MEDICAL TECHNOLOGY FUND | 14.72% | Via IHI | −9.92% |
 UBOTUnited Robotics & Artificial Intelligence ETF | 8.65% | Via BOTZ | −19.25% |
 SCBIHEALT(SSFE)SCB Healthcare Innovation | 4.32% | Via BNP Paribas Funds Health Care Innovators | +15.53% |
 TGHDIGITISCO Global Digital Health Equity Fund | 3.38% | Via UBS (Lux) Digital Health Equity | +3.88% |
| UHCRMFUnited Global Healthcare RMF | 2.63% | Via United Global Healthcare Fund | +15.57% |
| UGHUnited Global Healthcare Fund | 2.60% | Via United Global Healthcare Fund | +15.64% |
| UOBSHCUOB Smart Global Healthcare Fund | 2.60% | Via United Global Healthcare Fund | +15.82% |
 BCARERMFBualuang Global Health Care RMF | 2.39% | Via Wellington Global Health Care Equity Fund | +22.64% |
| BCAREBualuang Global Health Care Fund | 2.38% | Via Wellington Global Health Care Equity Fund | +23.02% |
| BCARESSFBualuang Global Health Care Super Savings Fund | 2.37% | Via Wellington Global Health Care Equity Fund | +22.81% |
Yearly average over the last 4 years · Latest annual sales 10.1B USD
For every 100 dollars of sales, about 28 dollars is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now 18.5% below its 1-year high
| Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenue | 5.7B USD | 6.2B USD | 7.1B USD | 8.4B USD | 10.1B USD |
| Gross profit | 4.0B USD | 4.2B USD | 4.7B USD | 5.6B USD | 6.6B USD |
| Operating profit | 1.8B USD | 1.6B USD | 1.8B USD | 2.3B USD | 2.9B USD |
| Net profit | 1.7B USD | 1.3B USD | 1.8B USD | 2.3B USD | 2.9B USD |
| EPS (diluted) | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| Gross margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Operating margin | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Net margin | 29.9% | 21.2% | 25.2% | 27.8% | 28.4% |
| Operating cash flow | 2.1B USD | 1.5B USD | 1.8B USD | 2.4B USD | 3.0B USD |
| Free cash flow | 1.8B USD | 958.0M USD | 750.0M USD | 1.3B USD | 2.5B USD |
| Total assets | 13.6B USD | 13.0B USD | 15.4B USD | 18.7B USD | 20.5B USD |
| Total liabilities | 1.6B USD | 1.9B USD | 2.0B USD | 2.2B USD | 2.5B USD |
| Shareholders' equity | 12.0B USD | 11.1B USD | 13.4B USD | 16.5B USD | 17.9B USD |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 447.95 | 447.24 | Above |
| 20 days | 437.14 | 437.03 | Above |
| 50 days | 406.28 | 417.75 | Above |
| 100 days | 396.50 | 413.96 | Above |
| 200 days | 431.85 | 430.75 | Above |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 72.83 | Down |
| MACD(12,26) | 13.33 | Up |
| ADX(14) | 29.85 | Neutral |
| ATR(14) % of price | 1.83 | Neutral |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
UOBAM4BBLAM3ONEAM1SCBAM1TISCOASSET1| Fund | ISRG weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| ONE-MEDTECH | 14.72% | IHI | −9.92% | 1.90% |
| UBOT | 8.65% | BOTZ | −19.25% | 0.72% |
| SCBIHEALT(SSFE) | 4.32% | BNP Paribas Funds Health Care Innovators | +15.53% | 0.11% |
| TGHDIGI | 3.38% | UBS (Lux) Digital Health Equity | +3.88% | 1.29% |
| UHCRMF | 2.63% | United Global Healthcare Fund | +15.57% | 1.86% |
| UGH | 2.60% | United Global Healthcare Fund | +15.64% | 1.88% |
| UOBSHC | 2.60% | United Global Healthcare Fund | +15.82% | 1.86% |
| BCARERMF | 2.39% | Wellington Global Health Care Equity Fund | +22.64% | 1.48% |
| BCARE | 2.38% | Wellington Global Health Care Equity Fund | +23.02% | 1.24% |
| BCARESSF | 2.37% | Wellington Global Health Care Equity Fund | +22.81% | 1.23% |
| Master fund | Thai funds using this route | Master fund's ISRG weight |
|---|---|---|
| United Global Healthcare Fund | 3 | 2.63% |
| Wellington Global Health Care Equity Fund | 3 | 2.39% |
| iShares U.S. Medical Devices ETF | 1 | 14.72% |
| Global X Robotics & Artificial Intelligence ETF | 1 | 8.65% |
| BNP Paribas Funds Health Care Innovators | 1 | 4.32% |
| UBS (Lux) Digital Health Equity | 1 | 3.38% |
